ClinConnect ClinConnect Logo
Search / Trial NCT06763185

A1 Beta-casein-free Milk in Milk-intolerant Participants

Launched by A2 MILK COMPANY LTD. · Jan 1, 2025

Trial Information

Current as of July 23, 2025

Completed

Keywords

Milk Free Of A1 Type Beta Casein Conventional Cow's Milk Gastrointestinal Symptoms

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female participants aged 18 to 68 years
  • Irregularly consumed milk
  • Had self-reported mild-to-moderate digestive discomfort after milk consumption
  • Had normal electrocardiograms and blood pressure during quiet respiration
  • Exclusion Criteria:
  • Known allergies to dairy products
  • Severe milk intolerance
  • A history of faecal impaction
  • Having suffered from GI disorders (e.g., irritable bowel syndrome, colitis, ulcerative colitis, or coeliac disease)
  • Currently being administered drugs for cardiovascular or metabolic disease
  • Trying to lose weight by following a diet or exercise regimen
  • Took any appetite or weight loss drugs for the previous three months

About A2 Milk Company Ltd.

a2 Milk Company Ltd. is a leading dairy nutrition company dedicated to providing high-quality products that focus on the unique benefits of A2 protein. Based in New Zealand and operating globally, the company specializes in milk and dairy products that are free from the A1 beta-casein protein, which some studies suggest may be linked to digestive discomfort. Committed to scientific research and innovation, a2 Milk Company Ltd. actively sponsors clinical trials to explore the health implications of A2 protein consumption, reinforcing its mission to enhance the wellbeing of consumers through superior dairy nutrition.

Locations

Baton Rouge, Louisiana, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported